Vanda Pharmaceuticals Inc.·4

Feb 27, 4:13 PM ET

Polymeropoulos Mihael Hristos 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 27, 2025

Insider Transaction Report

Form 4
Period: 2025-02-27
Polymeropoulos Mihael Hristos
DirectorPresident and CEOOther
Transactions
  • Purchase

    Common Stock

    2025-02-27$4.76/sh+10,000$47,6002,351,730 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4